Download FREE Report Sample
Download Free sampleHER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors
HER2 Inhibitors Market contains market size and forecasts of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in Global, including the following market information:
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors include F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc and Puma Biotechnology, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Segment Percentages, by Type, 2021 (%)
Monotherapy
Combination Therapy
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd
Merck & Co., Inc
Novartis AG
Pfizer Inc
Puma Biotechnology, Inc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
